Rheumatoid arthritis trials in Argentina

4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)

  Where

  Buenos Aires, Ciudad Autnoma de Buenos Aires, Ciudad Autonoma Buenos Aires, Mar del Plata, San Juan, San Miguel de Tucumán

  Age

  18 years and over

  People

  160 worldwide

  Run by

  Hoffmann-La Roche

  See details and how to joinNCT07137598
• Phase 2Taking people
  A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis

  Where

  CABA, Ciudad de Buenos Aires, Córdoba, San Isidro, San Miguel de Tucumán

  Age

  18 years and over

  People

  320 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07276581
• Phase 1Taking people
  A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)

  Where

  Buenos Aires, San Miguel de Tucumán

  Age

  18 years to 70 years

  People

  44 worldwide

  Run by

  GlaxoSmithKline

  See details and how to joinNCT07371468 · EU 2025-522932-15-00
• No phaseTaking people
  Registry of Autoimmune Interstitial Lung Disease

  Where

  Buenos Aires

  Age

  18 years and over

  People

  1,000

  Run by

  EPIMAR registry

  See details and how to joinNCT05365009